# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Benchmark analyst Bruce Jackson reiterates Movano (NASDAQ:MOVE) with a Speculative Buy and maintains $2 price target.
Following the positive outcome of a recent agency meeting, the Company will continue to work closely with the FDA to bring this...
Movano (NASDAQ:MOVE) reported quarterly losses of $(0.06) per share. This is a 64.71 percent increase over losses of $(0.17) pe...
Movano Evie Ring's generating $1 million in sales during the first 10 days "bodes well for the full commercial launch.&...
Benchmark analyst Bruce Jackson initiates coverage on Movano (NASDAQ:MOVE) with a Speculative Buy rating and announces Price...
Movano Health (Nasdaq: MOVE) announced major advances in the accuracy of its heart rate in motion algorithm following the imple...
Pioneering partnership advances innovative health monitoring, setting the stage for future enterprise opportunities.PLEASANTON,...